4967 — Kobayashi Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥400bn
- ¥321bn
- ¥173bn
- 92
- 36
- 27
- 51
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 90,557 | 94,338 | 109,046 | 104,533 | 79,836 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 54,105 | 52,829 | 55,147 | 47,853 | 52,984 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 163,046 | 164,225 | 181,889 | 172,892 | 158,331 |
Net Property, Plant And Equipment | 21,180 | 20,821 | 22,524 | 34,778 | 47,665 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 233,732 | 238,366 | 252,554 | 255,827 | 267,473 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 53,767 | 50,107 | 50,703 | 51,809 | 56,111 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 61,075 | 55,783 | 56,954 | 57,927 | 62,657 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 172,657 | 182,583 | 195,600 | 197,900 | 204,816 |
Total Liabilities & Shareholders' Equity | 233,732 | 238,366 | 252,554 | 255,827 | 267,473 |
Total Common Shares Outstanding |